Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Eton Pharmaceuticals Q3 EPS $(0.02) Beats $(0.10) Estimate, Sales $7.03M Beat $6.26M Estimate

Author: Benzinga Newsdesk | November 09, 2023 05:30pm
Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.10) by 80 percent. This is a 83.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $7.03 million which beat the analyst consensus estimate of $6.26 million by 12.27 percent. This is a 118.33 percent increase over sales of $3.22 million the same period last year.

Posted In: ETON


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist